Schoenfeldt, Trine
Thompson, John F.
Lo, Serigne
Drzewiecki, Krzysztof T.
Stretch, Jonathan
Saw, Robyn P. M.
Spillane, Andrew
Shannon, Kerwin
Uren, Roger F.
Chakera, Annette H.
Nieweg, Omgo E.
Funding for this research was provided by:
Kræftens Bekæmpelse
Reinholdt W. Jorck og Hustrus Fond
Knud Højgaard Fonden
Melanoma Institute Australia
Article History
Received: 15 August 2022
Accepted: 3 November 2022
First Online: 3 December 2022
Disclosures
: John F. Thompson has received honoraria for advisory board participation from BMS Australia, MSD Australia, GSK, and Provectus Inc, as well as travel and conference support from GSK, Provectus Inc, and Novartis. Robyn P. M. Saw has received honoraria for advisory board participation from MSD, Novartis, and Qbiotics and speaking honoraria from BMS and Novartis. The remaining authors have no conflicts of interest.